NEJM Published Daraxonrasib and Its Critic Published His Math the Same Week
The peer-reviewed paper landed on May 6. A peer of the principal investigators landed a denominator-tightening critique two days earlier.
Kenji Nakamura
Bureau: Tokyo
McGill Published Two Bone Papers in Nature This Week and One Finds a Fat-Burning Switch Too
One enzyme governs whether you burn fat for warmth and whether your bones harden — and the drug-screen pipeline is funded through 2029.
Right Whale Season Closed at 23, the NOAA Write-Up Is Up, the Gulf Sighting Is in the Record
Twenty-three calves, the best season since 2009. The mom-calf pair sighted in the Gulf of America is now in the record.
A CPS1 Deficiency Anniversary, the Custom Base-Edit Paper Is One Year On and Quiet
May 15 marks one year since the NEJM published the world's first personalized base-editing therapy — and the follow-up dataset is not yet public.
A Puppy Is Now the Name of an FDA-Cleared Blood Cancer Drug
Sonrotoclax (Beqalzi) got FDA accelerated approval May 13 for relapsed/refractory mantle cell lymphoma — the first BCL2 inhibitor for MCL and first new in the class in a decade.